Ex Parte BAKKER et al - Page 6




          Appeal No. 1997-0975                                       Page 6           
          Application No. 08/389,303                                                  

               From the above, we determine that either "bone," as used in            
          the appealed claims, includes collagenous body tissues or the               
          claimed bone contacting includes indirect contact with bone via             
          ligament and/or other body tissues.  Note also that the claimed             
          limitation "... to bind the prosthetic device to bone by contact            
          between said prosthetic device and bone" (claim 54) does not call           
          for a particular type of bond or direct bone contact such that              
          the claimed method would have excluded, for example, the nose               
          implant use taught by Jones.                                                
               With regard to the § 103 rejection, we agree with the                  
          examiner that the teachings of Jones regarding the use of the               
          implant for bonding to collagenous body tissue would have                   
          reasonably suggested to one of ordinary skill in the art the use            
          of the prosthetic devices for bonding to bone.  Jones broadly               
          teaches the prosthetic material for use in an animal body, which            
          is inclusive of bone contacting uses.  Jones further teaches the            
          prosthetic materials may be cast or compression molded (column 6)           
          indicating the prosthetic would have structural rigidity in                 
          addition to bicompatible properties.  Thus, a skilled artisan               
          would have had a reasonable expectation of success in using the             
          device for hard body (bone) implant utilities.  Compare American            
          Standard Inc. v. Pfizer Inc., 722 F. Supp. 86, 131, 14 USPQ2d               








Page:  Previous  1  2  3  4  5  6  7  8  9  10  Next 

Last modified: November 3, 2007